The Netherlands' Minister for Economic Affairs, Maria van der Hoeven, has called on drugmakers to position themselves in the public eye better and to take more pride in their achievements. The call comes in an article published by Nefarma, the national research-based pharmaceutical association, in its monthly newsletter Nefarma&.
Ms van der Hoeven praised the R&D contribution of the pharmaceutical sector to the Netherlands' economy, equal to over 10% of the country's total R&D investment and 15% of drugmakers' turnover on average. However, she also warned that the international perception of the Netherlands as a place to carry out drug research is not as high as it should be and that the Ministry of Economic Affairs and the Ministry of Education would be presenting proposals to improve intellectual cooperation between businesses and academia.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze